Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas

Pathology Research and Practice

Volumn 207, Issue 5, 2011, Pages 285-289

  Ersoz, Safak ^a   Mungan, Sevdegul ^a   Cobanoglu, Umit ^a   Turgutalp, Havvanur ^a   Ozoran, Yavuz ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Claudin 1; Claudin 4; Colon carcinoma; Immunochemistry; Stereologic method

Indexed keywords

CLAUDIN 1; CLAUDIN 4;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; COLON CARCINOMA; COLON POLYP; COLON SURGERY; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

ADENOCARCINOMA, MUCINOUS; ADENOMATOUS POLYPS; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79955477306     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.01.011     Document Type: Article

References (27)

1. Swisshelm K., Macek R., Kubbies M. Role of claudins in tumorigenesis. Adv. Drug Deliv. Rev. 2005, 57:919-928.
2. Schneeberger E.E., Lynch R.D. The tight junction: a multifunctional complex. Am. J. Physiol. Cell Physiol. 2004, 286:1213-1228.
3. Balda M.S., Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate erb-2 expression. Eur. Mol. Biol. Org. 2000, 19:2024-2033.
4. Tokes A.M., Kulka J., Paku S., Szik A., Paska C., Novak P.K., Szilak L., Kiss A., Bogi K., Schaff Z. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 2005, 7:296-305.
5. Kramer F., White K., Kubbies M., Swisshelm K., Weber B.H. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum. Genet. 2000, 107:249-256.
6. Resnick M.B., Konkin T., Routhier J., Sabo E., Pricolo V.E. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod. Pathol. 2005, 18:511-518.
7. Oliveria S.S., Oliveria I.M., De Souza V., Morgado-Diaz J.A. Claudins upregulation in human colorectal cancer. FEBS Lett. 2005, 579:6179-6185.
8. Miwa N., Furuse M., Tsukita S., Niikawa N., Nakamura Y., Furukawa Y. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol. Res. 2000, 12:469-476.
9. Iacobuzio-Donahue C.A., Maitra A., Shen-Ong G.L., van Heek T., Ashfaq R., Meyer R., et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 2002, 160:1239-1249.
10. Fluge O., Bruland O., Akslen L.A., Lillehaug J.R., Varhaug J.E. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 2006, 16:161-175.
11. Rangel L.B., Agarwal R., D'Souza T., Pizer E.S., Alo P.L., Lancaster W.D., et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 2003, 9:2567-2575.
12. Resnick M.B., Gavilanez M., Newton E., Konkin T., Bhattacharya B., Britt D.E., Sabo E., Moss S.F. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum. Pathol. 2005, 36:886-892.
13. Kominisky S.L., Vali M., Korz D., Gabig T.G., Waitzman S.A., Argani P., Sukumar S. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin-3 and claudin-4. Am. J. Pathol. 2004, 164:1627-1633.
14. Long H., Crean C.D., Lee W.H., Cummings O.W., Gabig T.G. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 2001, 61:7878-7881.
15. Nichols L.S., Ashfaq R., Iacobuzio-Donahue C.A. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am. J. Clin. Pathol. 2004, 121:226-230.
16. Oliveria S.S., Morgado-Diaz J.A. Claudins:multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol. Life Sci. 2007, 64:17-28.
17. Hamilton S.R., Aaltonen L.A. Tumours of the Digestive System. World Health Organization Classification of Tumours 2000, IARC Press, Lyon, pp. 10-25.
18. Greene F.L., Page D.L., Fleming I.D., et al. AJCC: Cancer Staging Handbook: From the AJCC Cancer Staging Manual 2002, Springer-Verlag, New York, pp. 127-129. 6th ed.
19. Gundersen H.J.G. Stereology of arbitrary particles. J. Microsc. 1986, 143:3-45.
20. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 1991, 231:482-497.
21. Halici Z., Keles O.N., Unal D., et al. Chronically administered risperidone did not change the number of hepatocytes in rats: a stereological and histopathological study. Basic Clin. Pharmacol. Toxicol. 2008, 102:426-432.
22. Gundersen H.J.G., Jensen E.B. The efficacy of systematic sampling in stereology and its prediction. J. Microsc. 1987, 147:229-326.
23. Dhawan P., Singh A.B., Deane N.G., No Y., Shiou S.R., Schmidt C., Neff J., Washington M.K., Beauchamp R.D. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest. 2005, 115:1765-1776.
24. Montgomery E., Mamelak A.J., Gibson M., Maitra A., Sheikh S., Amr S.S., Yang S., et al. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl. Immunohistochem. Mol. Morphol. 2006, 14:24-30.
25. Takala H., Saarnio J., Wiik H., Soini Y. Claudins 1,3,4,5 and 7 in esophagial cancer: loss of claudin-3 and 4 expression is associated with metastatic behavior. APMIS 2007, 115:838-847.
26. Soini Y., Tommolla S., Helin H., Martikainen P. Claudins 1, 3,4 and 5 in gastric carcinoma, loss of Claudin expression associates with diffuse subtype. Virchows Arch. 2006, 448:52-58.
27. Michl P., Barth C., Buchholz M., Lerch M., Rolke M., Holzmann K.H., et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 2003, 63:6265-6271.